PMDA drug package insert
マキロンパッチエース
PMDA OTC drug · 第一三共ヘルスケア株式会社 · package insert Mar 22, 2022
Key facts
| Brand names | マキロンパッチエース |
|---|---|
| Companies | 製造販売元／救急薬品工業株式会社,販売会社／第一三共ヘルスケア株式会社 |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 貼付剤 |
| OTC effect category | 鎮痛・鎮痒・収れん・消炎薬（パップ剤を含む） |
| Package insert date | Mar 22, 2022 |
| PMDA document key | 230064_J0601006918 |
| PMDA company code | 230064 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: